Is Livagen FDA approved?
No. This profile records Livagen as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE LIVER REVITALIZER
Lys-Glu-Asp-Ala
Livagen is a synthetic tetrapeptide bioregulator that can actually interact with your DNA to influence gene expression. It's been shown to activate genes in immune cells that may have become "silenced" with age. It may help restore youthful immune function and cellular repair capacity.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Livagen as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 10-20 mg daily (injection or oral).
Schedule: daily. Cycle: 10-20 days on, 3-6 months break. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Interacts with DNA to reactivate silenced genes in lymphocytes
Boosts lymphocyte function and immune resilience
Promotes tissue regeneration and cell renewal
Reduces oxidative stress and inflammatory markers
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.